Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety, tolerability, pharmacodynamics, and pharmacokinetics of RO7823653 in participants with Diabetic Macular Edema. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• RO7823653

Snippet

Sponsor: Genentech, Inc. | Conditions: Diabetic Macular Edema | Phase 1 | Status: RECRUITING